Edition:
United Kingdom

Hikma Pharmaceuticals PLC (HIK.L)

HIK.L on London Stock Exchange

1,854.50GBp
21 Sep 2018
Change (% chg)

-19.00 (-1.01%)
Prev Close
1,873.50
Open
1,862.00
Day's High
1,888.00
Day's Low
1,854.50
Volume
1,015,188
Avg. Vol
581,806
52-wk High
2,033.00
52-wk Low
814.20

Chart for

About

Hikma Pharmaceuticals Plc is a pharmaceutical company. The Company is focused on developing, manufacturing and marketing a range of both branded and non-branded generic and in-licensed products. The Company's segments include Branded, Injectables, Generics and Others. It sells branded generics and in-licensed patented products... (more)

Overall

Beta: 1.34
Market Cap(Mil.): £2,897.33
Shares Outstanding(Mil.): 240.65
Dividend: 8.50
Yield (%): --

Financials

  HIK.L Industry Sector
P/E (TTM): 22.78 30.93 32.76
EPS (TTM): 0.53 -- --
ROI: 4.67 15.07 14.61
ROE: 6.88 16.59 16.33

Hikma raising injectable opioids output to help ease shortage at U.S. hospitals

LONDON London-listed pharmaceutical group Hikma said on Wednesday it was increasing its supply of hydromorphone to U.S. hospitals to help ease a shortage of injectable opioids used to treat patients.

18 Jul 2018

Hikma raising injectable opioids output to help ease shortage at U.S. hospitals

LONDON, July 18 London-listed pharmaceutical group Hikma said on Wednesday it was increasing its supply of hydromorphone to U.S. hospitals to help ease a shortage of injectable opioids used to treat patients.

18 Jul 2018

Earnings vs. Estimates